Paul Tudor Jones Ionis Pharmaceuticals Inc Transaction History

Tudor Investment Corp Et Al

$29 Billion
Q1 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 11,500 shares of IONS stock, worth $385,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,500

Previous 6,900 66.67%

Holding current value

$385,365

Previous $241,000 43.57%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.06 - $51.86 $1.62 Million - $2.09 Million	40,381 Added 308.3%	53,479 $2.14 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $477,422 - $624,774	13,098 New	13,098 $624,000
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $1.17 Million - $1.45 Million	-33,552 Reduced 46.23%	39,025 $1.6 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $1.22 Million - $1.49 Million	36,212 Added 99.58%	72,577 $2.59 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $566,302 - $709,709	15,256 Added 72.27%	36,365 $1.37 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $1.94 Million - $2.58 Million	-53,083 Reduced 71.55%	21,109 $934,000
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $1.42 Million - $1.92 Million	44,667 Added 151.29%	74,192 $2.75 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $4.45 Million - $5.51 Million	-148,861 Reduced 83.45%	29,525 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $594,843 - $815,267	-23,227 Reduced 11.52%	178,386 $5.43 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $3.41 Million - $4.13 Million	101,727 Added 101.84%	201,613 $6.76 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $3.45 Million - $4.72 Million	99,886 New	99,886 $3.98 Million
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $2.02 Million - $2.69 Million	-44,644 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $2.12 Million - $2.81 Million	44,644 New	44,644 $2.12 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $540,930 - $704,883	-11,546 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $480,313 - $732,016	11,546 New	11,546 $546,000
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $860,858 - $1.05 Million	-14,576 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $747,687 - $1.04 Million	12,042 Added 475.22%	14,576 $937,000
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $561,004 - $860,483	-10,601 Reduced 80.71%	2,534 $206,000
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $569,664 - $782,057	13,135 New	13,135 $710,000

Others Institutions Holding IONS

# of Institutions

401

Shares Held

146M

Call Options Held

916K

Put Options Held

552K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.76B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account